Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from CML28

By Han Jun-Feng   Zhao Ting-Ting   Liu Hong-Li   Lin Zhi-Hua   Wang Hui-Ming   Ruan Zhi-Hua   Zou Li-Yun   Wu Yu-Zhang  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 12, 2006-12 ,pp. : 1575-1583

Springer Publishing Company

Access to resources Recommend Favorite

The cytotoxic T cell response to peptide analogs of the HLA-A*0201-restricted MUC1 signal sequence epitope, M1.2

By Mitchell Malcolm   Lund Teri   Sewell Andrew   Marincola Francesco   Paul Elyse   Schroder Kim   Wilson Darcy   Kan-Mitchell June  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 3, 2007-03 ,pp. : 287-301

Springer Publishing Company

Access to resources Recommend Favorite

Two novel squamous cell carcinoma antigen-derived HLA-A*0201-binding peptides induce in vitro and in vivo CD8+ cytotoxic T lymphocyte responses

By                  

International Journal of Oncology, Vol. 42, Iss. 4, 2013-01 ,pp. : 1482-1492

Spandidos Publications

Access to resources Recommend Favorite

Identification of a new hTERT-derived HLA-A*0201 restricted, naturally processed CTL epitope

By Thorn Mette   Wang Mingjun   Kløverpris Henrik   Schmidt Esben   Fomsgaard Anders   Wenandy Lynn   Berntsen Annika   Brunak Søren   Buus Søren   Claesson Mogens  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 11, 2007-11 ,pp. : 1755-1763

Springer Publishing Company

Access to resources Recommend Favorite

Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide

By              

International Journal of Oncology, Vol. 42, Iss. 3, 2013-01 ,pp. : 831-838

Spandidos Publications

Access to resources Recommend Favorite